Pruritus in adult dermatomyositis

Z. Shirani, M. J. Kucenic, C. L. Carroll, A. B. Fleischer, S. R. Feldman, Gil Yosipovitch, J. L. Jorizzo

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Dermatomyositis has a significant clinical component of pruritus that has not yet been studied. Pruritus can significantly affect the life of patients. The aim of the present work was to study the degree of pruritus experienced by patients. A four-question survey was sent to patients with documented dermatomyositis. The survey used a 100-mm Visual Analogue Scale (VAS) to describe current, worst and daily pruritus, and the effect this has on daily activities. Twenty-six subjects returned completed questionnaires: four had no pruritus; the majority had a significant amount with means above 50 on the VAS. A mean of 44.6 was found for the effect on daily life. Further studies should be performed to examine the prevalence and severity of pruritus in this population and it's effect on their quality of life. Clinicians must be aware of the significant pruritus and provide adequate therapy to improve quality of life.

Original languageEnglish (US)
Pages (from-to)273-276
Number of pages4
JournalClinical and Experimental Dermatology
Volume29
Issue number3
DOIs
StatePublished - May 1 2004
Externally publishedYes

Fingerprint

Dermatomyositis
Pruritus
Visual Analog Scale
Quality of Life
Population
Surveys and Questionnaires

ASJC Scopus subject areas

  • Dermatology

Cite this

Shirani, Z., Kucenic, M. J., Carroll, C. L., Fleischer, A. B., Feldman, S. R., Yosipovitch, G., & Jorizzo, J. L. (2004). Pruritus in adult dermatomyositis. Clinical and Experimental Dermatology, 29(3), 273-276. https://doi.org/10.1111/j.1365-2230.2004.01510.x

Pruritus in adult dermatomyositis. / Shirani, Z.; Kucenic, M. J.; Carroll, C. L.; Fleischer, A. B.; Feldman, S. R.; Yosipovitch, Gil; Jorizzo, J. L.

In: Clinical and Experimental Dermatology, Vol. 29, No. 3, 01.05.2004, p. 273-276.

Research output: Contribution to journalArticle

Shirani, Z, Kucenic, MJ, Carroll, CL, Fleischer, AB, Feldman, SR, Yosipovitch, G & Jorizzo, JL 2004, 'Pruritus in adult dermatomyositis', Clinical and Experimental Dermatology, vol. 29, no. 3, pp. 273-276. https://doi.org/10.1111/j.1365-2230.2004.01510.x
Shirani Z, Kucenic MJ, Carroll CL, Fleischer AB, Feldman SR, Yosipovitch G et al. Pruritus in adult dermatomyositis. Clinical and Experimental Dermatology. 2004 May 1;29(3):273-276. https://doi.org/10.1111/j.1365-2230.2004.01510.x
Shirani, Z. ; Kucenic, M. J. ; Carroll, C. L. ; Fleischer, A. B. ; Feldman, S. R. ; Yosipovitch, Gil ; Jorizzo, J. L. / Pruritus in adult dermatomyositis. In: Clinical and Experimental Dermatology. 2004 ; Vol. 29, No. 3. pp. 273-276.
@article{e921c9248582403db30a515fe5cfbeb1,
title = "Pruritus in adult dermatomyositis",
abstract = "Dermatomyositis has a significant clinical component of pruritus that has not yet been studied. Pruritus can significantly affect the life of patients. The aim of the present work was to study the degree of pruritus experienced by patients. A four-question survey was sent to patients with documented dermatomyositis. The survey used a 100-mm Visual Analogue Scale (VAS) to describe current, worst and daily pruritus, and the effect this has on daily activities. Twenty-six subjects returned completed questionnaires: four had no pruritus; the majority had a significant amount with means above 50 on the VAS. A mean of 44.6 was found for the effect on daily life. Further studies should be performed to examine the prevalence and severity of pruritus in this population and it's effect on their quality of life. Clinicians must be aware of the significant pruritus and provide adequate therapy to improve quality of life.",
author = "Z. Shirani and Kucenic, {M. J.} and Carroll, {C. L.} and Fleischer, {A. B.} and Feldman, {S. R.} and Gil Yosipovitch and Jorizzo, {J. L.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1111/j.1365-2230.2004.01510.x",
language = "English (US)",
volume = "29",
pages = "273--276",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Pruritus in adult dermatomyositis

AU - Shirani, Z.

AU - Kucenic, M. J.

AU - Carroll, C. L.

AU - Fleischer, A. B.

AU - Feldman, S. R.

AU - Yosipovitch, Gil

AU - Jorizzo, J. L.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Dermatomyositis has a significant clinical component of pruritus that has not yet been studied. Pruritus can significantly affect the life of patients. The aim of the present work was to study the degree of pruritus experienced by patients. A four-question survey was sent to patients with documented dermatomyositis. The survey used a 100-mm Visual Analogue Scale (VAS) to describe current, worst and daily pruritus, and the effect this has on daily activities. Twenty-six subjects returned completed questionnaires: four had no pruritus; the majority had a significant amount with means above 50 on the VAS. A mean of 44.6 was found for the effect on daily life. Further studies should be performed to examine the prevalence and severity of pruritus in this population and it's effect on their quality of life. Clinicians must be aware of the significant pruritus and provide adequate therapy to improve quality of life.

AB - Dermatomyositis has a significant clinical component of pruritus that has not yet been studied. Pruritus can significantly affect the life of patients. The aim of the present work was to study the degree of pruritus experienced by patients. A four-question survey was sent to patients with documented dermatomyositis. The survey used a 100-mm Visual Analogue Scale (VAS) to describe current, worst and daily pruritus, and the effect this has on daily activities. Twenty-six subjects returned completed questionnaires: four had no pruritus; the majority had a significant amount with means above 50 on the VAS. A mean of 44.6 was found for the effect on daily life. Further studies should be performed to examine the prevalence and severity of pruritus in this population and it's effect on their quality of life. Clinicians must be aware of the significant pruritus and provide adequate therapy to improve quality of life.

UR - http://www.scopus.com/inward/record.url?scp=2442712805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442712805&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2230.2004.01510.x

DO - 10.1111/j.1365-2230.2004.01510.x

M3 - Article

C2 - 15115510

AN - SCOPUS:2442712805

VL - 29

SP - 273

EP - 276

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 3

ER -